Jan 29 |
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
|
Dec 27 |
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 15 |
Adaptive Biotechnologies: MRD Success In A Challenging Market
|
Dec 13 |
Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
|
Dec 12 |
Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?
|
Dec 12 |
Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails
|
Dec 11 |
16 Best Penny Stocks To Buy For 2024
|
Dec 9 |
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
|
Dec 8 |
Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
|
Dec 5 |
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
|